1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Neptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc.

NEPTF
Neptune Wellness Solutions Inc.US flagOther OTC
0.00
USD
- -
- -
453.00Market Cap
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
444.93
590.3
558.63
590.58
16,134.39
9,049.33
12,353.22
15,258.22
12,891.48
12,986.22
14,303.16
14,164.62
7,127.52
23.74
Basic EPS, GAAP
-53.94
-59.89
-56.32
-381.72
-13,770.86
-16,790.02
-4,077.26
9,675.68
-12,232.01
-26,722.2
-49,765.66
-21,762.48
-8,190.15
-32.49
Free Cash Flow per Basic Share
-146.28
-185.17
-241.64
-481.96
-29,054.7
-24,459.12
-6,929.2
-6,974.95
-9,095.66
-20,066.42
-25,718.49
-16,463.78
-3,995.78
-9.63
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-45.08
90.64
405.12
867.31
22,053.08
16,352.66
12,705.36
27,046.33
14,985.53
22,102.73
23,599.41
-1,779.56
-8,357.53
-50.17
Tangible Book Value per Share
237.93
424.45
913.33
1,257.08
52,282.08
42,805.24
29,083.2
41,104.72
28,789.12
33,270.93
34,802.06
4,938.83
-4,279.89
-34
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Sales/Revenue/Turnover
12
17
19
25
18
12
17
21
18
21
35
49
53
39
Operating Margin (%)
-24.67
-9.17
-29.96
-59.63
-192.97
-273.6
-70.78
-81.5
-93.34
-234.55
-263.05
-141.31
-93.86
-119.18
Depreciation Expense
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
19
- -
- -
1
Net Income, GAAP
-1
-2
-2
-16
-15
-22
-6
14
-17
-43
-123
-75
-60
-54
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-12.12
-10.15
-10.08
-64.64
-85.35
-185.54
-33.01
63.41
-94.88
-205.77
-347.93
-153.64
-114.91
-136.83
Working Capital
4
10
24
41
43
33
18
20
3
15
55
7
-17
-57
LT Debt
5
4
3
2
9
11
15
- -
- -
1
14
14
17
2
Total Equity
8
14
33
55
58
58
49
67
52
101
138
61
-28
-52
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-23.41
-64.03
-48.9
-97.77
-28.31
49.25
-58.66
-151.17
-262.33
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
10
11
26
LT Borrowings
16
17
- -
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
2
5
Market Capitalization
- -
- -
1

Working Capital

FRC

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
23
23
17
Cash, Cash Equivalents & STI
1
5
1
Accounts Receivable, Net
6
5
4
Inventories
14
12
10
Total Current Liabilities
45
50
73
Payables & Accruals
29
30
31
ST Debt
10
11
26
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.23%
-18.43%
-145.3%
Free Cash Flow
35.77%
44.02%
-47.99%
Net Income, GAAP
41.15%
9.53%
-19.36%
Sales/Revenue/Turnover
15.13%
22.97%
7.82%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
10
13
15
12
49
2023
16
12
12
12
53
2024
11
9
8
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-5,702.4
-3,722.9
-5,023.1
- -
-21,762.48
2023
-1,150.78
-151.17
186.85
- -
-8,190.15
2024
-821.33
-1.38
-4.14
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Michael A. de Geus
Full Time Employees
50
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
545 Promenade du Centropolis Laval QC Canada H7T 0A3
IPO Date
Aug 13, 2007
CIK
0001401395
Website
neptunecorp.com
Similar Companies
Parnell Pharmaceuticals Holdings Ltd (PARNF)
Knight Therapeutics Inc. (GUD.TO)
Craftport Cannabis Corp. (CFT.CN)
Tilray Brands, Inc. (TLRY)
Ortin Global Ltd. (ORTINGLOBE.NS)
Planet Based Foods Global Inc. (PBFFF)
Business
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company focused on health and wellness products, including nutraceuticals and organic baby food; its core offerings encompass omega-3 fish oils and nutritional supplements under brands such as Biodroga featuring MaxSimil absorption technology, vegan multi-omega gummies and soft gels under Forest Remedies, and organic baby food and toddler snacks under Sprout Organics; the company provides turnkey product development, extraction, and supply chain solutions leveraging expertise in marine oils, grain oils, and specialized ingredients. Neptune serves distributors, retail outlets, grocery stores, and e-commerce channels including forestremedies.com and sproutorganics.com, with operations spanning Canada, the United States, and international markets. Founded in 1998 and headquartered in Laval, Quebec, Canada, the company targets consumers seeking plant-based, sustainable lifestyle brands in the nutraceuticals and organic foods segments. Recent developments include the appointment of Michael De Geus as interim president and CEO following Michael Cammarata's resignation in February 2024, alongside Cedrick Billequey as interim COO; Neptune increased its ownership in Sprout Organics to approximately 89.5% in 2023 via debt-to-equity exchange and retains Stifel to explore strategic alternatives such as monetization, partnerships, or divestitures for the unit; earlier efforts encompassed a non-binding letter of intent in 2023 to acquire Datasys Group for data-marketing and AI capabilities, a strategic review launched in 2023 aiming for pure-play CPG focus by 2024, and Nasdaq delisting proceedings.